Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Eisai China Inc. |
---|---|
Information provided by: | Eisai Medical Research Inc. |
ClinicalTrials.gov Identifier: | NCT00474409 |
The purpose of this study is to determine the efficacy and safety of Betahistine Mesilate in the treatment of patients with vertigo caused by Cerebral Infarction in posterior circulation.
Condition | Intervention | Phase |
---|---|---|
Vertigo |
Drug: Merislon |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Investigator), Active Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Multicenter, Placebo-Controlled, Double-Blind Study To Evaluate The Efficacy And Safety Of Betahistine Mesilate In The Treatment Of Patients With Vertigo Caused By Cerebral Infarction In Posterior Circulation |
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
1. Patients that have a clinical diagnosis of posterior circulation infarction and vertigo occurring within 1 month after the infarction.
China | |
Beijing Tiantan Hospital | |
Beijing, China, 100050 | |
Beijing Hospital | |
Beijing, China, 100730 | |
Shanghai Huashan Hospital | |
Shanghai, China, 200040 | |
Shanghai Renji Hospital | |
Shanghai, China, 20001 |
Principal Investigator: | Wang Yong Jun | Beijing Tiantan Hospital |
Study ID Numbers: | MRS-CHN-001 |
Study First Received: | May 3, 2007 |
Last Updated: | December 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00474409 |
Health Authority: | China: State Food and Drug Administration |
Vertigo Posterior circulation infarction |
Otorhinolaryngologic Diseases Cerebral Infarction Stroke Vascular Diseases Central Nervous System Diseases Betahistine Ischemia Vestibular Diseases Brain Diseases Ear Diseases |
Cerebrovascular Disorders Vertigo Histamine Signs and Symptoms Necrosis Histamine phosphate Neurologic Manifestations Brain Ischemia Brain Infarction Infarction |
Neurotransmitter Agents Vasodilator Agents Molecular Mechanisms of Pharmacological Action Nervous System Diseases Physiological Effects of Drugs Histamine Agents Cardiovascular Agents |
Pharmacologic Actions Pathologic Processes Histamine Agonists Therapeutic Uses Cardiovascular Diseases Labyrinth Diseases |